Paediatric Vaccine Market: By Type, By Technology, By Application and By Region Forecast 2019-2030

Paediatric Vaccine Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit, Recombinant, Polysaccharide, Conjugate Vaccines, Others), By Application (Infectious Disease, Diphtheria, Tetanus and Pertussis, Allergy, Influenza, Pneumococcal Disease, Measles, Mumps, and Rubella, Others) and By Region Forecast 2019-2030

 Paediatric Vaccine Market size was valued at US$ 40.7 billion in 2023 and grow at 10.3% CAGR from 2019 - 2023. Paediatric vaccinations are vital items used to prevent children from dangerous infections. They function by boosting the immune system to recognize and kill specific viruses or bacteria, resulting in a faster and more effective response if exposed to these pathogens in the future. These vaccinations endure accurate safety testing, including clinical trials, to ensure that they fulfil demanding quality criteria before being approved and distributed in countries around the world. Factors such as increased knowledge of vaccination advantages, economic growth, government assistance, and novel vaccine development initiatives by key companies are propelling the further. However, factors such as high vaccine costs, limited access in remote locations, and competition from lower cost biosimilars are impeding market growth.

 Paediatric Vaccine Market Key Developments

  • On May 10, 2024, the World Health Organization (WHO) prequalified a novel vaccine for dengue. TAK-003 is the second dengue vaccine to be prequalified by the WHO. Takeda developed it as a live-attenuated vaccine containing weakened forms of the four dengue virus serotypes.
  • On October 20, 2023, The FDA has approved PENBRAY, the first vaccine to prevent the five most common serogroups that cause meningococcal disease in adolescents. PENBRAY offers the broadest serogroup coverage (meningococcal groups A, B, C, W, and Y) of any meningococcal vaccine available in the U.S., potentially simplifying the complex immunization schedule.

Paediatric Vaccine Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

10.3%

Largest Market

North America

Fastest Growing Market

Asia pacific

Paediatric Vaccine Market Dynamics

The paediatric vaccines market is characterized by various dynamic factors that drive growth. Increasing global awareness of the benefits of vaccination for preventing childhood illnesses is an important factor. Governments and healthcare organizations around the world promoting vaccination as an important public health precaution, which is helping to increase vaccine uptake. Technological improvements and innovations in vaccine development are critical for market growth. The introduction of new vaccinations that target a wider range of diseases, combined with advances in vaccine formulations and delivery systems, improves efficacy and safety profiles. For Example, Conjugate vaccines, which link polysaccharides to carrier proteins, have transformed vaccination by stimulating higher immune responses in both newborns and adults which resultant to drive the market.

Moreover, rising prevalence of paediatric infections, such as influenza and tetanus, as well as chronic problems like multiple sclerosis in teenagers, are further driving the market. Despite these factors, constraints such as high vaccine costs, particularly for novel formulations and combination vaccines, impede market expansion. Issues with vaccination supply chains, storage needs, and distribution logistics all have an impact on market dynamics. However, continuous research and development efforts, combined with strategic partnerships between pharmaceutical firms and healthcare providers, continue to drive innovation and overcome these difficulties, indicating a bright future for the market globally.

Paediatric Vaccine Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024 - 2030

Market Size in 2023

US$ 40.7 billion

Market CAGR

10.3%

By Type

  • Monovalent
  • Multivalent

By Technology

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Subunit
  • Recombinant
  • Polysaccharide
  • Conjugate Vaccines
  • Others

By Application

  • Infectious Disease
  • Diphtheria, Tetanus and Pertussis
  • Allergy
  • Influenza
  • Pneumococcal Disease
  • Measles, Mumps, and Rubella
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The paediatric vaccine market was valued at US$ 40.7 billion in 2023 and is projected to reach growing at a CAGR of 10.3 %.

The increasing incidence of several diseases in children, including pertussis, influenza, diphtheria, and tetanus, among other infectious and non-infectious diseases, is one of the primary drivers driving the growth of the pediatric vaccine market.

The increased use of novel vaccines has resulted in an increase in worldwide vaccination coverage, which has a further impact on the market.

Market research is segmented based on type, technology, application, and region.

North America is expected to have the largest market share and the greatest CAGR throughout the forecast period.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Paediatric Vaccine Market Introduction 
2.1.Global Paediatric Vaccine Market  - Taxonomy
2.2.Global Paediatric Vaccine Market  - Definitions
2.2.1.Type 
2.2.2.Technology
2.2.3.Application
2.2.4.Region
3. Global Paediatric Vaccine Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Paediatric Vaccine Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Paediatric Vaccine Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Monovalent
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Multivalent
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Paediatric Vaccine Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Live Attenuated Vaccines
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Inactivated Vaccines
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Toxoid Vaccines
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Subunit
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Recombinant
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Polysaccharide
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Conjugate Vaccines
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Others
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7. Global Paediatric Vaccine Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Infectious Disease
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diphtheria, Tetanus and Pertussis
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Allergy
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Influenza
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Pneumococcal Disease
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Measles, Mumps, and Rubella
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Others
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8. Global Paediatric Vaccine Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Paediatric Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Monovalent
9.1.2.Multivalent
9.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Live Attenuated Vaccines
9.2.2.Inactivated Vaccines
9.2.3.Toxoid Vaccines
9.2.4.Subunit
9.2.5.Recombinant
9.2.6.Polysaccharide
9.2.7.Conjugate Vaccines
9.2.8.Others
9.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Infectious Disease
9.3.2.Diphtheria, Tetanus and Pertussis
9.3.3.Allergy
9.3.4.Influenza
9.3.5.Pneumococcal Disease
9.3.6.Measles, Mumps, and Rubella
9.3.7.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Paediatric Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Monovalent
10.1.2.Multivalent
10.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Live Attenuated Vaccines
10.2.2.Inactivated Vaccines
10.2.3.Toxoid Vaccines
10.2.4.Subunit
10.2.5.Recombinant
10.2.6.Polysaccharide
10.2.7.Conjugate Vaccines
10.2.8.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Infectious Disease
10.3.2.Diphtheria, Tetanus and Pertussis
10.3.3.Allergy
10.3.4.Influenza
10.3.5.Pneumococcal Disease
10.3.6.Measles, Mumps, and Rubella
10.3.7.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Paediatric Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Monovalent
11.1.2.Multivalent
11.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Live Attenuated Vaccines
11.2.2.Inactivated Vaccines
11.2.3.Toxoid Vaccines
11.2.4.Subunit
11.2.5.Recombinant
11.2.6.Polysaccharide
11.2.7.Conjugate Vaccines
11.2.8.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Infectious Disease
11.3.2.Diphtheria, Tetanus and Pertussis
11.3.3.Allergy
11.3.4.Influenza
11.3.5.Pneumococcal Disease
11.3.6.Measles, Mumps, and Rubella
11.3.7.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Paediatric Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Monovalent
12.1.2.Multivalent
12.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Live Attenuated Vaccines
12.2.2.Inactivated Vaccines
12.2.3.Toxoid Vaccines
12.2.4.Subunit
12.2.5.Recombinant
12.2.6.Polysaccharide
12.2.7.Conjugate Vaccines
12.2.8.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Infectious Disease
12.3.2.Diphtheria, Tetanus and Pertussis
12.3.3.Allergy
12.3.4.Influenza
12.3.5.Pneumococcal Disease
12.3.6.Measles, Mumps, and Rubella
12.3.7.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Paediatric Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Monovalent
13.1.2.Multivalent
13.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Live Attenuated Vaccines
13.2.2.Inactivated Vaccines
13.2.3.Toxoid Vaccines
13.2.4.Subunit
13.2.5.Recombinant
13.2.6.Polysaccharide
13.2.7.Conjugate Vaccines
13.2.8.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Infectious Disease
13.3.2.Diphtheria, Tetanus and Pertussis
13.3.3.Allergy
13.3.4.Influenza
13.3.5.Pneumococcal Disease
13.3.6.Measles, Mumps, and Rubella
13.3.7.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Sinovac
14.2.2.Sanofi
14.2.3.Novartis AG
14.2.4.Abbott
14.2.5.AstraZeneca Plc
14.2.6.Merck & Co Inc
14.2.7.Emergent BioSolutions Inc
14.2.8.Serum Institute of India Pvt.
14.2.9.GSK
14.2.10.Pfizer Inc
14.2.11.CSL Limited
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Sinovac
  • Sanofi
  • Novartis AG
  • Abbott
  • AstraZeneca Plc
  • Merck & Co Inc
  • Emergent BioSolutions Inc
  • Serum Institute of India Pvt.
  • GSK
  • Pfizer Inc
  • CSL Limited

Related Industry Reports